A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)
Clinical trial NCT02293902 · COMPLETED
Trial details
- NCT number
- NCT02293902
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-10-01
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.